BioNTech SE is a German biotechnology company specializing in the development of personalized immunotherapies for the treatment of cancer and other diseases. Its groundbreaking mRNA-based technology has gained worldwide recognition, especially its COVID-19 vaccine developed in collaboration with Pfizer. With a strong focus on innovation and scientific excellence, BioNTech continues to lead the way in the field of transformative medicine.
